DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF

Introduction: Linezolid is a last-resort antibiotic for infections caused by multidrug-resistant microorganisms. It is widely used for off-label indications and for longer than recommended treatment durations, exposing patients at higher risk of adverse drug reactions (ADRs), notably thrombocytopenia. This study aimed to investigate ADR incidence and risk factors, identify thrombocytopenia-related trough levels based on treatment duration, and evaluate the performance of predictive scores for ADR development. Methods: Adult in- and outpatients undergoing linezolid therapy were enrolled in thre... Mehr ...

Verfasser: Hélène Thirot
David Fage
Antonia Leonhardt
Philippe Clevenbergh
Tatiana Besse-Hammer
Jean Cyr Yombi
Olivier Cornu
Caroline Briquet
Maya Hites
Frédérique Jacobs
Gert-Jan Wijnant
Sebastian G. Wicha
Frédéric Cotton
Paul M. Tulkens
Anne Spinewine
Françoise Van Bambeke
Dokumenttyp: Dataset
Erscheinungsdatum: 2024
Schlagwörter: Pharmacology / Basic Pharmacology / Clinical Pharmacology and Therapeutics / Clinical Pharmacy and Pharmacy Practice / Pharmaceutical Sciences / Pharmacogenomics / Toxicology (incl. Clinical Toxicology) / Pharmacology and Pharmaceutical Sciences not elsewhere classified / linezolid / thrombocytopenia / adverse drug reaction / therapeutic drug monitoring / anemia / Buzelé score / neurotoxicity
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-26924802
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3389/fphar.2024.1310309.s001